Inogen (INGN) FCF Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 72.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.00 |
| Dec 31, 2025 | 1,954.00 |
| Sep 30, 2025 | 1,041.00 |
| Jun 30, 2025 | 70.00 |
| Mar 31, 2025 | 187.00 |
| Dec 31, 2024 | -1,551.00 |
| Sep 30, 2024 | 1,320.00 |
| Jun 30, 2024 | -642.00 |
| Mar 31, 2024 | -1,138.00 |
| Dec 31, 2023 | -1,988.00 |
| Sep 30, 2023 | -658.00 |
| Jun 30, 2023 | -1,789.00 |
| Mar 31, 2023 | -769.00 |
| Dec 31, 2022 | -2,894.00 |
| Sep 30, 2022 | -2,522.00 |
| Jun 30, 2022 | -1,393.00 |
| Mar 31, 2022 | -1,957.00 |
| Dec 31, 2021 | 247.00 |
| Sep 30, 2021 | -2,488.00 |
| Jun 30, 2021 | -386.00 |
| Mar 31, 2021 | -925.00 |
| Dec 31, 2020 | -305.00 |
| Sep 30, 2020 | -1,761.00 |
| Jun 30, 2020 | -439.00 |
| Mar 31, 2020 | -2,517.00 |
| Dec 31, 2019 | -179.00 |
| Sep 30, 2019 | 188.00 |
| Jun 30, 2019 | -389.00 |
| Mar 31, 2019 | -1,251.00 |
| Dec 31, 2018 | -4,462.00 |
| Sep 30, 2018 | -443.00 |
| Jun 30, 2018 | 1,799.00 |
| Mar 31, 2018 | -346.00 |
| Dec 31, 2017 | 1,037.00 |
| Sep 30, 2017 | 1,301.00 |
| Jun 30, 2017 | -276.00 |
| Mar 31, 2017 | 3,038.00 |
| Dec 31, 2016 | 198.00 |
| Sep 30, 2016 | -3,326.00 |
| Jun 30, 2016 | 2,307.00 |
| Mar 31, 2016 | 1,243.00 |